{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:51:23Z","timestamp":1785783083886,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ejphar.2004.03.044","type":"journal-article","created":{"date-parts":[[2004,5,12]],"date-time":"2004-05-12T10:25:44Z","timestamp":1084357544000},"page":"243-250","source":"Crossref","is-referenced-by-count":103,"title":["In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats"],"prefix":"10.1016","volume":"492","author":[{"given":"Akiyoshi","family":"Ohtake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Sasamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.03.044_BIB1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0022-5347(17)38030-8","article-title":"Muscarinic receptor stimulation of phosphoinositide hydrolysis in the human isolated urinary bladder","volume":"146","author":"Andersson","year":"1991","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB2","first-page":"16","article-title":"Functional diversity of muscarinic receptor subtypes in cellular signal transduction and growth","author":"Ashkenazi","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB3","first-page":"R517","article-title":"Prejunctional M1 facilitatory and M2 inhibitory muscarinic receptors mediate rat bladder contractility","volume":"274","author":"Braverman","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2004.03.044_BIB4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1569-9056(03)80112-4","article-title":"YM905: results of a randomised, double-blind placebo-controlled trial in patients with symptomatic overactive bladder","author":"Cardozo","year":"2003","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB5","first-page":"381","article-title":"YM905 appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a european placebo-and tolterodine-controlled, phase-II, dose-finding study","volume":"21","author":"Chapple","year":"2002","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB6","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of an inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002512-200118040-00005","article-title":"Tolterodine\u2014a review of its use in the treatment of overactive bladder","volume":"18","author":"Clemett","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejphar.2004.03.044_BIB8","doi-asserted-by":"crossref","first-page":"C1063","DOI":"10.1152\/ajpcell.1991.261.6.C1063","article-title":"Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems","volume":"261","author":"Dai","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB9","first-page":"E97","article-title":"Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose\u2013response curves","volume":"235","author":"DeLean","year":"1978","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0773.1996.tb00181.x","article-title":"Selective muscarinic receptor agonists and antagonists","volume":"78","author":"Eglen","year":"1996","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB11","first-page":"4","article-title":"Selective effector coupling of muscarinic acetylcholine receptor subtypes","author":"Fukuda","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-2999(98)00214-3","article-title":"Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists","volume":"349","author":"Gillberg","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0022-5347(01)67039-3","article-title":"Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells","volume":"154","author":"Harriss","year":"1995","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB14","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/sj.bjp.0701048","article-title":"Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo","volume":"120","author":"Hegde","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00210-002-0554-x","article-title":"M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland","volume":"366","author":"Ikeda","year":"2002","journal-title":"Naunyn-Schmiedebergs Arch. Pharmakol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1006\/bbrc.1998.8395","article-title":"Acetylcholine acts on M3 muscarinic receptors and induces the translocation of aquaporin5 water channel via cytosolic Ca2+ elevation in rat parotid glands","volume":"245","author":"Ishikawa","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0922-4106(90)90052-Y","article-title":"Muscarinic M3 receptors are coupled to two signal transduction pathways in rat submandibular cells","volume":"188","author":"Laniyonu","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1476-5381.1993.tb13737.x","article-title":"Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equation","volume":"109","author":"Lazareno","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB19","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1476-5381.1995.tb15065.x","article-title":"Characterization of the functional muscarinic receptors in the rat urinary bladder","volume":"116","author":"Longhurst","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB20","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1073\/pnas.97.17.9579","article-title":"Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype","volume":"97","author":"Matsui","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1464-410X.1990.tb14992.x","article-title":"Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability","volume":"66","author":"Moore","year":"1990","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB22","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/S0024-3205(99)00188-5","article-title":"Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland","volume":"64","author":"Moriya","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","article-title":"Tolterodine\u2014a new bladder-selective antimuscarinic agent","volume":"327","author":"Nilvebrant","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB24","article-title":"The binding profile of the novel muscarinic receptor antagonist darifenacin against the five cloned human muscarinic receptors expressed CHO cells","volume":"117","author":"Nunn","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1113\/jphysiol.1994.sp020342","article-title":"M1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder","volume":"480","author":"Somogyi","year":"1994","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5347(17)38459-8","article-title":"Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo","volume":"145","author":"Thuroff","year":"1991","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB27","first-page":"959","article-title":"Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins","volume":"273","author":"Wang","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.044_BIB28","article-title":"The effects of darifenacin and oxybutynin on bladder function and salivation in the conscious rat","volume":"120","author":"Williamson","year":"1997","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904003012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904003012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T13:52:42Z","timestamp":1549720362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904003012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":28,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0014299904003012"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.03.044","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}